Antimicrobial activity of eravacycline and other comparative agents on aerobic and anaerobic bacterial pathogens in Taiwan: A clinical microbiological study
Open Access
- 27 March 2024
- journal article
- research article
- Published by Elsevier in Journal of Global Antimicrobial Resistance
- Vol. 37, 93-99
Abstract
No abstract availableKeywords
Funding Information
- Chang Gung Memorial Hospital Linkou
This publication has 29 references indexed in Scilit:
- In vitro activity of eravacycline and comparators against Gram-negative and Gram-positive bacterial isolates collected from patients globally between 2017 and 2020Journal of Global Antimicrobial Resistance, 2023
- In vitro susceptibility of common Enterobacterales to eravacycline in TaiwanJournal of Microbiology, Immunology and Infection, 2022
- Antimicrobial susceptibility of bacteremic vancomycin-resistant Enterococcus faecium to eravacycline, omadacycline, lipoglycopeptides, and other comparator antibiotics: Results from the 2019–2020 Nationwide Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART)International Journal of Antimicrobial Agents, 2021
- Efficacy and Tolerability of Eravacycline in Bacteremic Patients with Complicated Intra-Abdominal Infection: A Pooled Analysis from the IGNITE1 and IGNITE4 StudiesSurgical Infections, 2021
- Eravacycline: A Review in Complicated Intra-Abdominal InfectionsDrugs, 2019
- In vitro activity of eravacycline and comparator antimicrobials against 143 recent strains of Bacteroides and Parabacteroides speciesAnaerobe, 2018
- Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosisThe Lancet Infectious Diseases, 2018
- Susceptibilities of clinical Clostridium difficile isolates to antimicrobials: a systematic review and meta-analysis of studies since 1970Clinical Microbiology and Infection, 2018
- Imipenem–Relebactam and Meropenem–Vaborbactam: Two Novel Carbapenem-β-Lactamase Inhibitor CombinationsDrugs, 2017
- Tigecycline (GAR-936) activity against Streptococcus gallolyticus (bovis) and viridans group streptococciDiagnostic Microbiology and Infectious Disease, 2007